Evolvere BioSciences
Y Combinator
ARTIFICIAL-INTELLIGENCE
AI-POWERED-DRUG-DISCOVERY
BIOTECH
THERAPEUTICS
BIOTECHNOLOGY
Current Round
Pre Seed
About
Making Next-Generation Antibiotics that Outpace Bacterial Evolution
Prediction Markets
Would Evolvere BioSciences have an exit before end of 2030?
46% YES
Closes: Dec. 31, 2030
Would Evolvere BioSciences get next round of funding before end of 2025?
83% YES
Closes: Dec. 31, 2025